Suppr超能文献

在格雷夫斯病患者血清中具有异质性的封闭性免疫球蛋白G的证实:针对促甲状腺激素受体的不同自身抗体可能共存。

Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor.

作者信息

Macchia E, Concetti R, Carone G, Borgoni F, Fenzi G F, Pinchera A

机构信息

Cattedra di Endocrinologia e Medicina Costituzionale, University of Pisa, Italy.

出版信息

Clin Endocrinol (Oxf). 1988 Feb;28(2):147-56. doi: 10.1111/j.1365-2265.1988.tb03650.x.

Abstract

Previous studies by us and others have shown that Graves' immunoglobulins G (IgGs) behaved as agonists or even antagonists of TSH. In this paper we have looked for the existence of IgG preparations without any thyroid stimulatory activity but able to significantly block the action of TSH in 128 hyperthyroid Graves' patients. The presence of TSH-binding inhibiting antibodies (TBIAb) and that of thyroid stimulating antibodies (TSAb) was evaluated by a radioreceptor assay using solubilized thyroid plasma membranes and by assaying the adenylate cyclase (AC) function of thyroid plasma membranes, respectively. Seventeen IgGs were negative for TSAb but positive for TBIAb in the screening, using only one concentration of IgG. Three kinds of activity were investigated in these IgGs at different doses: (1) TSH-binding inhibiting activity; (2) thyroid AC stimulating activity; and (3) the inhibition of TSH-induced AC stimulation. The results showed that the level of activity was not always dose-dependent. A significant (greater than 20%) inhibition of the TSH-dependent AC stimulation was present in 15 of the 17 IgGs examined: this inhibition was more elevated at lower than at higher doses in two preparations. No significant correlation was found between the three activities. In short, we have been able to demonstrate the existence of 'blocking' antibodies, apparently without any stimulatory activity, in some patients with Graves' disease. The diphasic pattern of the dose-response curves of some IgGs and the lack of correlation between the different activities can be explained by the co-existence in the sera of Graves' patients of different autoantibodies varying in concentration, binding affinity constant and intrinsic biological activity.

摘要

我们和其他研究团队之前的研究表明,格雷夫斯病免疫球蛋白G(IgG)可作为促甲状腺激素(TSH)的激动剂甚至拮抗剂。在本文中,我们在128例甲状腺功能亢进的格雷夫斯病患者中寻找无任何甲状腺刺激活性但能显著阻断TSH作用的IgG制剂。分别通过使用可溶性甲状腺质膜的放射受体测定法以及测定甲状腺质膜的腺苷酸环化酶(AC)功能来评估促甲状腺激素结合抑制抗体(TBIAb)和甲状腺刺激抗体(TSAb)的存在情况。在筛选过程中,仅使用一种IgG浓度,17种IgG的TSAb检测呈阴性,但TBIAb检测呈阳性。对这些IgG在不同剂量下的三种活性进行了研究:(1)TSH结合抑制活性;(2)甲状腺AC刺激活性;(3)对TSH诱导的AC刺激的抑制作用。结果表明,活性水平并不总是呈剂量依赖性。在检测的17种IgG中,有15种对TSH依赖性AC刺激有显著(大于20%)抑制作用:在两种制剂中,较低剂量时的抑制作用比较高剂量时更强。三种活性之间未发现显著相关性。简而言之,我们已经能够证明,在一些格雷夫斯病患者中存在明显无任何刺激活性的“阻断”抗体。某些IgG剂量反应曲线的双相模式以及不同活性之间缺乏相关性,可以通过格雷夫斯病患者血清中不同自身抗体的共存来解释,这些自身抗体在浓度、结合亲和常数和内在生物学活性方面存在差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验